# RYDAPT
> **NDA207997** · New Drug Application · Sponsor: NOVARTIS · Approved 2017-04-28
## Drug
- **FDA Application Number:** NDA207997
- **Application type:** New Drug Application
- **Brand name:** RYDAPT
- **Generic name:** RYDAPT
- **Active ingredients:** MIDOSTAURIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2017-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207997)
---
*MORVS · CC0 1.0*